Immediate-early gene expression in the brain of the thiamine-deficient rat

Journal of Molecular Neuroscience

Volumn 10, Issue 1, 1998, Pages 1-15

  Hazell, Alan S ^a   McGahan, Lynda ^b   Tetzlaff, Wolfram ^b   Bedard, Annie M ^b   Robertson, George S ^b   Nakabeppu, Yusaku ^c   Hakim, Antoine M ^b  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

Apoptosis; Immediate early gene; Programmed cell death; Selective vulnerability; Thiamine deficiency

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; IMMEDIATE EARLY GENE; IMMUNOHISTOCHEMISTRY; INFERIOR COLLICULUS; NERVE CELL NECROSIS; NONHUMAN; PATHOGENESIS; RAT; THALAMUS; THIAMINE DEFICIENCY;

EID: 0031814084     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02737081     Document Type: Article

References (51)

1. Aikawa H., Watanabe I. S., Furuse T., Iwasaki Y., Satoyoshi E., Sumi T., and Moroji T. (1984) Low energy levels in thiamine-deficient encephalopathy. J. Neuropath. Exp. Neurol. 43, 276-287.
2. Angel P., Allegretto E. A., Okino S. T., Hattori K., Boyle W. J., Hunter T., and Karin M. (1988) Oncogene jun encodes a sequence-specific trans-activator similar to AP-1. Nature 332(6160), 166-171.
3. Bartel D. P., Sheng M., Lau L. F., and Greenberg M. E. (1989) Growth factors and membrane depolarization activate distinct programs of early response gene expression: dissociation of fos and jun induction. Genes Dev. 3, 304-313.
4. Chomczynski P. and Sacchi N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162(1), 156-159.
5. Colotta F., Polentarutti N., Sironi M., and Mantovani A. (1992) Expression of c-fos and c-jun protooncogenes in programmed cell death induced by growth factor deprivation in lymphoid cell lines. J. Biol. Chem. 267, 18,278-18,283.
6. Curran T., Gordon M. B., Rubino K. L., and Sambucetti L. C. (1987) Isolation and characterization of the c-fos(rat) cDNA and analysis of post-translational modification in vitro. Oncogene 2, 79-84.
7. Dragunow M., Young D., Hughes P., MacGibbon G., Lawlor P., Singleton K., Sirimanne E., Beilharz E., and Gluckman P. (1993) Is c-jun involved in nerve cell death following status epilepticus and hypoxic-ischemic injury? Mol. Brain Res. 18, 347-352.
8. Estus S., Zaks W. J., Freeman R. S., Gruda M., Bravo R., and Johnson E. M. Jr. (1994) Altered gene expression in neurons during programmed cell death: Identification of c-jun as necessary for neuronal apoptosis. J. Cell. Biol. 127, 1717-1727.
9. Gentz R., Rauscher F. J., III, Abate C., and Curran T. (1989) Parallel association of Fos and Jun leucine zippers juxtaposes DNA binding domains. Science 243, 1695-1699.
10. Gerfen C. R. (1989) Quantification of in situ hybridization histochemistry for analysis of brain function. Meth. Neurosci. 1, 79-97.
11. González-Martín C., de Deigo I., Crespo D., and Fairen A. (1992) Transient c-fos expression accompanies naturally occurring cell death in the developing interhemispheric cortex of the rat. Dev. Brain Res. 68, 83-95.
12. Hai T. and Curran T. (1991) Cross-family dimerization of transcription factors Fos/Jun and ATF/ CREB alters DNA binding specificity. Proc. Natl. Acad. Sci. USA 88, 3720-3724.
13. Hakim A. M. and Pappius H. M. (1981) The effect of thiamine deficiency on local cerebral glucose utilization. Ann. Neurol. 9, 334-339.
14. Hakim A. M. and Pappius H. M. (1983) Sequence of metabolic, clinical, and histological events in experimental thiamine deficiency. Ann. Neurol. 13, 365-375.
15. Hakim A. M., Carpenter S., and Pappius H. M. (1983) Metabolic and histological reversibility of thiamine deficiency. J. Cereb. Blood Flow Metab. 3, 468-477.
16. Halazonetis T., Georgopoulos K., Greenberg M. E., and Leder P. (1988) c-Jun dimerizes with itself and with c-Fos, forming complexes of different DNA binding affinities. Cell 55, 917-924.
17. Ham J., Babij C., Whitfield J., Pfarr C. M., Lallemand D., Yaniv M., and Rubin L. (1995) A c-jun dominant mutant protects sympathetic neurons against programmed cell death. Neuron 14, 927-939.
18. Hazell A. S., Butterworth R. F., and Hakim A. M. (1993) Cerebral vulnerability is associated with selective increase in extracellular glutamate concentration in experimental thiamine deficiency. J. Neurochem. 61, 1155-1158.
19. Hazell A. S., Tetzlaff W., Robertson G. S., and Hakim A. M. (1994) Reversible increase in c-fos expression is localized to vulnerable regions of the thiamine deficient rat brain. Soc. Neurosci. Abst. 20, 415.
20. Hazell A. S., Hakim A. M., Senterman M. K., and Hogan M. J. (1998) Regional activation of L-type voltage-sensitive calcium channels in experimental thiamine deficiency. J. Neurosci. Res., in press.
21. Jorgensen M. B., Deckert J., Wright D. C., and Gehlert D. R. (1989) Delayed c-fos proto-oncogene expression in the rat hippocampus induced by transient global cerebral ischemia: an in situ hybridization study. Brain Res. 484, 393-398.
22. Kovary K. and Bravo R. (1991) Expression of different JUN and FOS proteins during the G0 to G1 transition in mouse fibroblasts: in vitro and in vivo associations. Mol. Cell. Biol. 11, 2451-2459.
23. Langlais P. J. and Zhang S. X. (1993) Extracellular glutamate is increased in thalamus during thiamine deficiency-induced lesions and is blocked by MK-801. J. Neurochem. 61, 2175-2182.
24. Li B.-H. and Rowland N. E. (1993) Dexfenfluramine induces Fos-like immunoreactivity in discrete brain regions in rats. Brain Res. Bull. 31, 43-48.
25. Matsushima K., MacManus J. P., and Hakim A. M. (1997) Apoptosis is restricted to the thalamus in thiamine-deficient rats. Neuroreport 8, 867-870.
26. McGahan L., Hazell A. S., Robertson G. S., and Hakim A. M. (1996) Differential expression of immediate early genes in the thiamine deficient rat brain. Soc. Neurosci. Abst. 22, 2135.
27. Milbrandt J. (1987) A nerve growth factor-induced gene encodes a possible transcriptional regulatory factor. Science 238, 797-799.
28. Morgan J. I. and Curran T. (1986) Role of ion flux in the control of c-fos expression. Nature 322, 552-555.
29. Morgan J. I., Cohen D. R., Hempstead J. L., and Curran T. (1987) Mapping patterns of c-fos expression in the central nervous system after seizure. Science 237, 192-197.
30. Mumberg D., Lucibello F. C., Schuermann M., and Muller R. (1991) Alternative splicing of fosB transcripts results in differentially expressed mRNAs encoding functionally antagonistic proteins. Genes Dev. 5, 1212-1223.
31. Munujos P., Vendrell M., and Ferrer I. (1993) Proto-oncogene c-fos induction in thiamine-deficient encephalopathy. Protective effects of nicardipine on pyrithiamine-induced lesions. J. Neurol. Sci. 118, 175-180.
32. Murphy T. H., Worley P. F., and Baraban J. M. (1991) L-type voltage-sensitive calcium channels mediate synaptic activation of immediate-early genes. Neuron 7, 625-635.
33. Nakabeppu Y. and Nathans D. (1991) A naturally occurring truncated form of FosB that inhibits Fos/Jun transcriptional activity. Cell 64, 751-759.
34. Nakabeppu Y., Ryder K., and Nathans D. (1988) DNA binding activities of three murine Jun proteins: stimulation by Fos. Cell 55, 907-915.
35. Nakabeppu Y., Oda S., and Sekiguchi M. (1993) Proliferative activation of quiescent Rat-1A cells by ΔFosB. Mol. Cell Biol. 13, 4157-4166.
36. Rauscher F. J. III, Cohen D. R., Curran T., Bos T. J., Vogt P. K., Bohmann D., Tijian R., and Franza B. R. Jr. (1988) Fos-associated protein p39 is the product of the jun proto-oncogene. Science 240, 1010-1016.
37. Robertson G. S., Tetzlaff W., Bedard A., St-Jean M., and Wigle N. (1995) c-fos mediates antipsychotic-induced neurotensin gene expression in the rodent striatum. Neuroscience 67, 534-344.
38. Saffen D. W., Cole A. J., Worley P. F., Christy B. A., Ryder K., and Baraban J. M. (1988) Convulsant-induced increase in transcription factor messenger RNAs in rat brain. Proc. Natl. Acad. Sci. USA 85, 7795-7799.
39. Schalling M., Dagerlind Å., Brené S., Hallman H., Djurfeldt M., Persson H., Terenius L., Goldstein M., Schlesinger D., and Hökfelt T. (1988) Coexistence and gene expression of phenylethanolamine N-methyltransferase, tyrosine hydroxylase, and neuropeptide tyrosine in the rat and bovine adrenal gland: effect of reserpine. Proc. Natl. Acad. Sci. USA 85, 8306-8310.
40. Sharp F. R., Bolger E., and Evans K. (1982) Thiamine deficiency limits glucose utilization and glial proliferation in brain lesions of symptomatic rats. J. Cereb. Blood Flow Metab. 2, 203-207.
41. Sheng M. and Greenberg M. E. (1990) The regulation and function of c-fos and other immediate- early genes in the nervous system. Neuron 4, 478-485.
42. Sheng M., McFadden G., and Greenberg M. E. (1990) Membrane depolarization and calcium induce c-fos transcription via phosphorylation of transcription factor CREB. Neuron 4, 477-485.
43. Smeyne R. J., Vendrell M., Hayward M., Baker S. J., Miao G. G., Schilling K., Robertson L. M., Curran T., and Morgan J. I. (1993) Continuous c-fos expression precedes programmed cell death in vivo. Nature 363, 166-169.
44. Sukhatme V. P., Cao X., Chang L. C., Tsai-Morris C-H., Stamenkovich D., Ferreira P. C. P., Cohen D. R., Edwards S. A., Shows T. B., Curran T., Le Beau M. M., and Adamson E. D. (1988) A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization. Cell 53, 37-43.
45. 3H]nimodipine in rat brain after transient forebrain ischemia. J. Cereb. Blood Flow Metab. 14, 397-405.
46. Thilmann R., Xie Y., Kleihues P., and Kiessling M. (1986) Persistent inhibition of protein synthesis precedes delayed neuronal death in postischemic gerbil hippocampus. Acta Neuropathol. 71, 88-93.
47. Troncoso J. C., Johnston M. V., Hess K. M., Griffin J. W., and Price D. L. (1981) Model of Wernicke's encephalopathy. Arch. Neurol. 38, 350-354.
48. Vogel S. and Hakim A. M. (1988) Effect of nimodipine on the regional cerebral acidosis accompanying thiamine deficiency in the rat. J. Neurochem. 51, 1102-1110.
49. Wessel T. C., Joh T. H., and Volpe B. T. (1991) In situ hybridization analysis of c-fos and c-jun expression in the rat brain following transient forebrain ischemia. Brain Res. 567, 231-240.
50. Yen J., Wisdom R. M., Tratner I., and Verma I. M. (1991) An alternative spliced form of FosB is a negative regulator of transcriptional activation and transformation by Fos proteins. Proc. Natl. Acad. Sci. USA 8, 5077-5081.
51. Zerial M., Toschi L., Ryseck R. P., Schuermann M., Muller R., and Bravo R. (1989) The product of a novel growth factor activated gene, fos B, interacts with JUN proteins enhancing their DNA binding activity. EMBO J. 8, 805-813.